How much does Wegovy cost per month in Ireland?
Wegovy costs around €279.95 a month in Ireland at the maintenance dose, which works out at roughly €3,359 a year for the medication alone. Add €35 to €90 for the initial consultation, €60 to €100 for baseline bloods and four to six follow-up reviews at €50 to €70 each, and a realistic first-year total is €3,700 to €3,900. From year two the monitoring load drops and the medication becomes almost the entire cost. Wegovy is licensed for weight management rather than diabetes, which affects what the State will and will not cover.
The monthly figure, and what it covers
Around €279.95 per month at the maintenance dose of 2.4 mg. One pen covers four weekly injections, so a month is one pen.
Your first four months cost the same but deliver less, because Wegovy titrates through 0.25, 0.5, 1.0 and 1.7 mg before reaching 2.4 mg at week 17. You pay a full monthly price for doses that were never expected to produce much weight loss. That is not a pricing quirk, it is how the medicine has to be introduced, but it is worth knowing before you budget.
The costs that are not the pen
Roughly €400 in year one, and it is the part people are not quoted.
- Initial consultation, €35 to €90. A GP is at the lower end, a private weight management clinic at the upper.
- Baseline bloods, €60 to €100. HbA1c, kidney, liver and thyroid function as a minimum.
- Follow-up reviews, €50 to €70 each. Four to six in the first year, more if you tolerate the titration poorly.
- Repeat prescriptions, €15 to €25 where your prescriber charges for them.
- Sharps bin. Small, but it exists.
From year two, expect the medication plus two reviews. Call it €3,500 annually, indefinitely, unless something changes.
How that compares to the alternatives
Rough monthly medication costs in Ireland, for context rather than as a recommendation.
- Wegovy, around €279.95 a month.
- Mounjaro, €554.95 for a two-pen package, so roughly €277 a month at a steady dose.
- Ozempic, €260 to €337 a month depending on strength, though it is licensed for diabetes rather than weight loss.
- Saxenda, from €149.99 for a single pen up to €529.99 for five, and it is a daily rather than weekly injection.
- Rybelsus, €198 to €260 for a 30-day supply depending on strength.
Wegovy and Mounjaro land close together per month. The difference is what you get for it: tirzepatide produced a larger average weight reduction in its trials than semaglutide did in its own.
What the State will cover
This is where most of the potential saving sits, and it turns on the indication your prescriber writes.
Wegovy is licensed specifically for weight management. Because the indication is weight rather than diabetes, it generally sits outside the Long Term Illness Scheme, which covers diabetes medicines with no income test.
The Drugs Payment Scheme still applies, and it caps a household at €80 a month across all prescribed medicines combined. Whether a private weight-management prescription is dispensed under it depends on how it is written and dispensed, which is a question for your prescriber and pharmacist rather than a general rule. Registering costs nothing and takes minutes, and a large number of people who would benefit have never done it.
Private health insurance rarely covers the medicine itself. Some policies contribute to consultations through outpatient benefit, usually above an excess. Ten minutes on the phone to your insurer is worth it before you assume either way.
Cost per kilogram, if you want a value measure
A crude but useful way to compare. In STEP-1, average weight reduction on Wegovy was 14.9 per cent over 68 weeks. For someone starting at 100 kg, that is about 14.9 kg over roughly 15.5 months, costing around €4,340 in medication.
That is approximately €290 per kilogram lost. Whether that represents value is a personal judgement, but it is a more honest number than the monthly figure, because it accounts for how long the result takes to arrive.
The question worth asking instead
Most people compare the monthly price against their budget. The more useful comparison is against duration.
Obesity is treated as a chronic condition, and the withdrawal studies are consistent: weight largely returns after stopping. In the STEP-4 study, participants who stopped semaglutide regained most of what they had lost over the following year. So the realistic commitment is not twelve months at €280. It is an open-ended one.
That is not an argument against treatment. It is an argument for going in with the actual number in mind, and for using the period on treatment to build the habits that determine what happens if you ever come off it.
How much does Wegovy cost per month: common questions
Around 279.95 euro a month at the maintenance dose of 2.4 mg, where one pen covers four weekly injections. Prices vary between pharmacies, so it is worth checking a few.
Roughly 3,359 euro for the medication alone. Adding the initial consultation, baseline bloods and four to six follow-up reviews brings a realistic first-year total to between 3,700 and 3,900 euro. Year two is usually around 3,500 euro.
The Drugs Payment Scheme caps a household at 80 euro a month across all prescribed medicines. Whether a private weight-management prescription is dispensed under it depends on how it is written and dispensed, which is a question for your prescriber and pharmacist.
They are close. Wegovy is around 279.95 euro a month and Mounjaro is 554.95 euro for a two-pen package, roughly 277 euro a month at a steady dose. The difference is in outcomes rather than price, with tirzepatide producing larger average weight reduction in its trials.
Rarely for the medicine itself. Some policies contribute towards consultations through outpatient benefit, usually above an excess. It is worth calling your insurer directly rather than assuming either way.
Roughly 290 euro per kilogram, based on the STEP-1 average of 14.9 per cent body weight over 68 weeks for someone starting at 100 kg. It is a crude measure but a more honest one than the monthly price, because it accounts for how long results take.